Interparfums Q2 Sales Rise 2% YoY, U.S. Business Leads Gains

For the second quarter of 2026, Interparfums posted a 2% increase in net sales to $341 million, compared with $334 million in the prior-year period. First-half of 2026 net sales also rose 2% to $686 million from $673 million a year earlier, supported by strength across several key brands and favorable currency movements.

The ongoing war in the Middle East remained a drag on performance, representing a 3% headwind in the second quarter and a 2% headwind during the first six months of 2026. Excluding this impact, organic sales increased 4% in the second quarter and 1% in the first half. Meanwhile, favorable dollar/euro exchange rates contributed a 1% positive foreign exchange impact in the second quarter and 3% in the first half of 2026.

Interparfums’ Europe-Based Sales Performance

Europe-based net sales declined 4% to $231 million in the second quarter from $241 million a year ago. The decline reflected a 5% organic sales drop, partially offset by a 1% favorable foreign exchange impact. For the first six months of 2026, Europe-based sales slipped 1%, despite a 3% benefit from foreign exchange. 

Several brands delivered mixed performances during the quarter. Jimmy Choo fragrance sales rebounded strongly, rising 23% in the second quarter and 8% in the first half, supported by continued momentum in the I Want Choo women's franchise and the successful launch of Jimmy Choo Man Parfum.

Coach fragrance sales declined 8% against a difficult comparison after last year's 42% growth, although first-half sales still increased 10% thanks to robust demand across existing lines and new Coach Woman and Coach Man fragrance extensions.

Montblanc fragrance sales were broadly flat during the quarter but increased 6% in the first half, benefiting from the continued success of the Montblanc Explorer Extreme line and the launch of Montblanc Legend Elixir earlier this year.

Meanwhile, Lacoste fragrance sales declined 19% in the second quarter and 16% in the first half, reflecting exceptionally strong comparison periods in 2025 and continued weakness in Eastern Europe, although management remains confident in the brand's long-term growth prospects.

Interparfums’ US-Based Metrics

U.S.-based net sales increased 18% to $113 million in the second quarter from $96 million a year earlier, driven by 17% organic growth and a 1% favorable foreign exchange impact. For the first half of 2026, U.S. sales rose 10%, including 8% organic growth and a 2% positive foreign exchange impact. 

GUESS, the company's largest U.S.-based brand, posted 10% growth in the second quarter and 11% in the first half, supported by the successful launch of Iconic Blue and the newest Amore Napoli fragrance.

Donna Karan/DKNY delivered a strong rebound, with fragrance sales increasing 28% in the quarter and 12% in the first half, reflecting healthy consumer demand across product categories and strengthening e-commerce momentum.

Ferragamo was among the standout performers, with fragrance sales surging 41% in the second quarter and 17% during the first half, driven by strong demand for the Signorina line and the launch of Ferragamo Sublime Leather.

Meanwhile, Roberto Cavalli fragrance sales declined 9% in the second quarter due to a difficult year-over-year comparison and macroeconomic weakness in the Middle East, its largest market. However, first-half sales still increased 8%, supported by new fragrance extensions and continued success of the Serpentine franchise.

IPAR’s Management Outlook

Interparfums remains cautiously optimistic despite continued macroeconomic and geopolitical uncertainty. Management highlighted the resilience of the global fragrance category and expects its diversified brand portfolio, disciplined execution and strong innovation pipeline to support growth.

Looking ahead, the company expects a rich lineup of fragrance extensions during the second half of 2026, followed by several major product launches planned for 2027 and 2028, positioning the business for continued expansion as market conditions improve. 

This Zacks Rank #3 (Hold) stock has gained 22.9% in the past month compared with the industry’s rise of 8.3%.

IPAR Price Performance vs. Industry

Image Source: Zacks Investment Research

Stocks Worth Considering

Duluth Holdings DLTH sells casual wear, workwear, outdoor apparel and accessories for men and women in the United States. DLTH presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Duluth Holdings’ current fiscal-year earnings implies growth of 39.5% from the year-ago figures. DLTH delivered a trailing four-quarter earnings surprise of 107.5%, on average. 

Vince Holding Corp. VNCE provides luxury apparel and accessories in the United States and internationally. At present, the company holds a Zacks Rank of 2 (Buy). VNCE delivered a trailing four-quarter earnings surprise of 635.7%, on average. 

The Zacks Consensus Estimate for Vince Holding’s current fiscal-year earnings indicates growth of 34.1% from the year-ago figures. 

Revolve Group, Inc. RVLV operates as an online fashion retailer for millennial and generation z consumers in the United States and internationally. It currently carries a Zacks Rank of 2. RVLV delivered a trailing four-quarter average earnings surprise of 52.1%.

The Zacks Consensus Estimate for Revolve Group’s current fiscal-year sales implies growth of 10.6%, from the year-ago figures.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research